Novo Nordisk A/S shares rise 1.38% premarket after positive market sentiment due to US-EU trade optimism.

Novo Nordisk A/S rose 1.38% in premarket trading. The positive movement in the stock price may be attributed to the overall optimistic market sentiment, as reported by LBBW-Analyst Andreas da Graça, who noted that despite geopolitical uncertainties, the market is dominated by optimism due to hopes of a resolution in the US-EU trade dispute.